Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04499625
Other study ID # B707201316423
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 2013
Est. completion date May 2018

Study information

Verified date July 2020
Source University of Liege
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Several approaches have been used in order to regenerate bone in the upper jaw in case of insufficient alveolar bone height for implant placement. However, new emerging techniques need to be assessed and compared to conventional methods in order to define their potential indications.

The purpose of the present randomized controlled clinical trial was to compare the clinical outcomes of two sinus floor elevation techniques: conventional lateral window technique versus a novel transalveolar approach using hydrodynamic ultrasonic device.


Recruitment information / eligibility

Status Completed
Enrollment 22
Est. completion date May 2018
Est. primary completion date May 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- edentulism in the posterior maxilla (unitary or plural)

- need of a sinus floor augmentation procedure before implant placement

Exclusion Criteria:

- any uncontrolled systemic disease

- ongoing chemo- or radiotherapy

- history of maxillary sinus diseases or acute sinus-related issues

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Sinus floor elevation

Device:
Sinus floor elevation using an ultrasonic device


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
University of Liege

Outcome

Type Measure Description Time frame Safety issue
Primary Sinus membrane perforation Presence/absence of sinus membrane perforation during the surgery During the surgery (from beginning to end)
Primary Surgical procedure duration The time measurement started from the administration of local anesthesia and ended when the placement of final suture was completed. The time was measured using a stopwatch. From beginning of surgery until the end of surgery
Primary Edema Presence/absence of edema postoperatively From the end of surgery up to 1 week postoperatively
Primary Hematoma Presence/absence of hematoma postoperatively From the end of surgery up to 1 week postoperatively
Primary Postsurgical bleeding Presence/absence of bleeding postoperatively From the end of surgery up to 1 week postoperatively
Primary Nasal discharge Presence/absence of nasal discharge postoperatively From the end of surgery up to 1 week postoperatively
Primary NSAID consumption Quantification of NSAID consumption per day up to 1 week postoperatively (tablets/per day) From the end of surgery up to 1 week postoperatively
Primary Patient related outcome measures (PROMs) PROMs were assessed with a questionnaire using a visual analogue scale (VAS), which was given to all participants in order to assess their perception before, during, and after the intervention. A graduated scale from 0 to 10 was used, with a lower score presenting a better outcome. From right before the surgery up to 1 week postoperatively
Secondary Radiographic outcomes Radiographic (CBCT) qualitative assessment of the gained volume (change in volume from baseline to 1 year postoperatively). From the baseline (surgery procedure) up to 1 year post-surgery
Secondary Implant survival rates Implant survival rates assessment at 1 year postoperatively. From the baseline (surgery procedure) up to 1 year post-surgery
See also
  Status Clinical Trial Phase
Recruiting NCT06259591 - Pedometer Coaching to Promote Postoperative Ambulation N/A
Recruiting NCT06035510 - Effect of Whey Protein Supplementation on Postoperative Outcomes After Gynecological Cancer Surgery N/A